ENDOGENOUS NORADRENALINE IMPAIRS THE PROSTAGLANDIN-INDUCED INHIBITION OF NORADRENALINE RELEASE

被引:19
作者
ALLGAIER, C
JAGER, T
HERTTING, G
机构
关键词
D O I
10.1007/BF00167051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:472 / 474
页数:3
相关论文
共 15 条
[1]   THE ADENOSINE RECEPTOR-MEDIATED INHIBITION OF NORADRENALINE RELEASE POSSIBLY INVOLVES A N-PROTEIN AND IS INCREASED BY ALPHA-2-AUTORECEPTOR BLOCKADE [J].
ALLGAIER, C ;
HERTTING, G ;
KUGELGEN, OV .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (02) :403-412
[2]  
ALLGAIER C, 1989, IN PRESS J NEUROCHEM
[3]   REGIONAL DISTRIBUTION OF ARACHIDONIC-ACID METABOLITES IN RAT-BRAIN FOLLOWING CONVULSIVE STIMULI [J].
BERCHTOLDKANZ, E ;
ANHUT, H ;
HELDT, R ;
NEUFANG, B ;
HERTTING, G .
PROSTAGLANDINS, 1981, 22 (01) :65-79
[4]   EFFECT OF PROSTAGLANDIN-E2 ON CENTRAL AND PERIPHERAL CATECHOLAMINE NEURONS [J].
BERGSTROM, S ;
FARNEBO, LO ;
FUXE, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1973, 21 (03) :362-368
[5]   REGULATION OF NORADRENALINE OVERFLOW IN RAT CEREBRAL-CORTEX BY PROSTAGLANDIN-E2 [J].
HILLIER, K ;
TEMPLETON, WW .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 70 (03) :469-473
[6]  
LIMBERGER N, 1988, N-S ARCH PHARMACOL, V338, P53
[7]   EFFECT OF PROSTAGLANDINS-D2, PROSTAGLANDINS-E2, AND PROSTAGLANDINS-F2-ALPHA ON CATECHOLAMINE RELEASE FROM SLICES OF RAT AND RABBIT BRAIN [J].
REIMANN, W ;
STEINHAUER, HB ;
HEDLER, L ;
STARKE, K ;
HERTTING, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 69 (04) :421-427
[8]   INFLUENCE OF EICOSANOIDS ON SEROTONIN RELEASE IN THE RAT-BRAIN - INHIBITION BY PROSTAGLANDIN-E1 AND PROSTAGLANDIN-E2 [J].
SCHLICKER, E ;
FINK, K ;
GOTHERT, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 335 (06) :646-651
[9]   CHANGES IN CYCLOOXYGENASE ACTIVITY AND PROSTAGLANDIN PROFILES DURING MONOAMINE METABOLISM IN RAT-BRAIN HOMOGENATES [J].
SEREGI, A ;
HERTTING, G .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1984, 14 (01) :113-121
[10]   INTERACTION BETWEEN INDOMETHACIN, OXYMETAZOLINE AND PHENTOLAMINE ON RELEASE OF [H-3]NORADRENALINE FROM BRAIN SLICES [J].
STARKE, K ;
MONTEL, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (09) :758-759